Immunosuppressive therapy in inflammatory cardiomyopathy

Research output: Contribution to journalArticle

Abstract

The role of immunosuppressive treatment in inflammatory cardiomyopathy is still controversial. Nevertheless, it is recommended in patients with eosinophilic myocarditis, granulomatous myocarditis, giant-cell myocarditis and lymphocytic myocarditis associated with connective tissue diseases or with rejection of a transplanted heart. There is growing evidence that some patients with idiopathic active myocarditis and cardiac dysfunction may benefit from immunosuppression. In the present review we define, through analysis of recent reports and the results of our own studies, the biological markers of candidates for immunosuppression.

Original languageEnglish
JournalEuropean Heart Journal, Supplement
Volume4
Issue numberI
DOIs
Publication statusPublished - Dec 2002

Fingerprint

Myocarditis
Immunosuppressive Agents
Cardiomyopathies
Immunosuppression
Therapeutics
Connective Tissue Diseases
Giant Cells
Biomarkers

Keywords

  • Autoantibodies
  • Immunosuppression
  • Inflammatory cardiomyopathy
  • Viruses

ASJC Scopus subject areas

  • Cardiology and Cardiovascular Medicine

Cite this

Immunosuppressive therapy in inflammatory cardiomyopathy. / Frustaci, A.; Pieroni, M.; Chimenti, C.

In: European Heart Journal, Supplement, Vol. 4, No. I, 12.2002.

Research output: Contribution to journalArticle

@article{a8972e7267fa493ba206146bf9c275ba,
title = "Immunosuppressive therapy in inflammatory cardiomyopathy",
abstract = "The role of immunosuppressive treatment in inflammatory cardiomyopathy is still controversial. Nevertheless, it is recommended in patients with eosinophilic myocarditis, granulomatous myocarditis, giant-cell myocarditis and lymphocytic myocarditis associated with connective tissue diseases or with rejection of a transplanted heart. There is growing evidence that some patients with idiopathic active myocarditis and cardiac dysfunction may benefit from immunosuppression. In the present review we define, through analysis of recent reports and the results of our own studies, the biological markers of candidates for immunosuppression.",
keywords = "Autoantibodies, Immunosuppression, Inflammatory cardiomyopathy, Viruses",
author = "A. Frustaci and M. Pieroni and C. Chimenti",
year = "2002",
month = "12",
doi = "10.1016/S1520-765X(02)90114-8",
language = "English",
volume = "4",
journal = "European Heart Journal, Supplement",
issn = "1520-765X",
publisher = "Oxford University Press",
number = "I",

}

TY - JOUR

T1 - Immunosuppressive therapy in inflammatory cardiomyopathy

AU - Frustaci, A.

AU - Pieroni, M.

AU - Chimenti, C.

PY - 2002/12

Y1 - 2002/12

N2 - The role of immunosuppressive treatment in inflammatory cardiomyopathy is still controversial. Nevertheless, it is recommended in patients with eosinophilic myocarditis, granulomatous myocarditis, giant-cell myocarditis and lymphocytic myocarditis associated with connective tissue diseases or with rejection of a transplanted heart. There is growing evidence that some patients with idiopathic active myocarditis and cardiac dysfunction may benefit from immunosuppression. In the present review we define, through analysis of recent reports and the results of our own studies, the biological markers of candidates for immunosuppression.

AB - The role of immunosuppressive treatment in inflammatory cardiomyopathy is still controversial. Nevertheless, it is recommended in patients with eosinophilic myocarditis, granulomatous myocarditis, giant-cell myocarditis and lymphocytic myocarditis associated with connective tissue diseases or with rejection of a transplanted heart. There is growing evidence that some patients with idiopathic active myocarditis and cardiac dysfunction may benefit from immunosuppression. In the present review we define, through analysis of recent reports and the results of our own studies, the biological markers of candidates for immunosuppression.

KW - Autoantibodies

KW - Immunosuppression

KW - Inflammatory cardiomyopathy

KW - Viruses

UR - http://www.scopus.com/inward/record.url?scp=0036897991&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0036897991&partnerID=8YFLogxK

U2 - 10.1016/S1520-765X(02)90114-8

DO - 10.1016/S1520-765X(02)90114-8

M3 - Article

AN - SCOPUS:0036897991

VL - 4

JO - European Heart Journal, Supplement

JF - European Heart Journal, Supplement

SN - 1520-765X

IS - I

ER -